These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Studies on the mechanism of stable graft-host tolerance in canine and human radiation chimeras. Storb R; Tsoi MS; Weiden PL; Graham TC; Thomas ED Transplant Proc; 1976 Dec; 8(4):561-4. PubMed ID: 11587 [No Abstract] [Full Text] [Related]
6. Cell-mediated immunity and serum blocking factor in tolerance produced in mice with antilymphocyte serum and bone marrow cell infusion. Wood ML; Gozzo JJ; Heppner G; Monaco AP Transplant Proc; 1972 Sep; 4(3):383-9. PubMed ID: 4263511 [No Abstract] [Full Text] [Related]
7. Persistence of cell-mediated cytotoxicity and serum blocking activity in highly tolerant rats. Wright PW; Bernstein ID; Hamilton B; Hellström KE Transplantation; 1975 May; 19(5):437-41. PubMed ID: 239476 [No Abstract] [Full Text] [Related]
8. [Immunological concepts relating to organ transplantation]. Dei Poli G; Massa G; Rosso PA; Dei Poli N Minerva Chir; 1980 Jun; 35(11):829-78. PubMed ID: 6450338 [No Abstract] [Full Text] [Related]
9. Relevance of major human histocompatibility determinants in clinical bone marrow transplantation. Hansen JA; O'Reilly RJ; Good RA; Dupont B Transplant Proc; 1976 Dec; 8(4):581-9. PubMed ID: 63170 [No Abstract] [Full Text] [Related]
12. The use of H-2 mutants as models for the study of T cell activation. McKenzie IF; Pang T; Blanden RV Immunol Rev; 1977; 35():179-230. PubMed ID: 70397 [No Abstract] [Full Text] [Related]
13. Genetic determinants for the graft-vs.-host reaction in the H-2 complex. Oppltová L; Démant P Transplant Proc; 1973 Dec; 5(4):1367-71. PubMed ID: 4149545 [No Abstract] [Full Text] [Related]
14. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity. Rouse BT; Wagner H J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454 [No Abstract] [Full Text] [Related]
15. Cell-mediated cell lysis in vitro: genetic control of killer cell production and target specificities in the mouse. Nabholz M; Vives J; Young HM; Meo T; Miggiano V; Rijnbeek A; Shreffler DC Eur J Immunol; 1974 May; 4(5):378-87. PubMed ID: 4277395 [No Abstract] [Full Text] [Related]
16. The genetic basis for cell-mediated lympholysis in mice. Sorensen SF; Hawkes SP Transplant Proc; 1973 Dec; 5(4):1361-6. PubMed ID: 4272808 [No Abstract] [Full Text] [Related]
17. Cellular immunogenetics of HLA: quantitative crossmatches for LD and CD determinants. Bach FH Transplant Proc; 1978 Mar; 10(1):63-6. PubMed ID: 76353 [No Abstract] [Full Text] [Related]
18. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections. Warren RP; Storb R; Weiden PL; Mickelson EM; Thomas ED Transplantation; 1976 Dec; 22(6):631-5. PubMed ID: 137561 [No Abstract] [Full Text] [Related]
19. Characterization of longstanding specific unresponsiveness in adult recipients of strongly histoincompatible hemopoietic stem cells. Müller-Ruchholtz W; Wottge HU; Kuhlencordt M; Wulff J Transplant Proc; 1977 Mar; 9(1):901-5. PubMed ID: 17204 [No Abstract] [Full Text] [Related]
20. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells. Kedar E; Bonavida B J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487 [No Abstract] [Full Text] [Related] [Next] [New Search]